BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4939990)

  • 1. [Clinical testing of Dibromdulcit in polycythemia vera].
    Szentkláray J; Sellei C
    Orv Hetil; 1971 Jun; 112(26):1523-5. PubMed ID: 4939990
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial clinical trial of dibromodulcitol (NSC-104800) in patients with advanced cancer.
    Keyes JW; Selawry OS; Hansen HH
    Cancer Chemother Rep; 1971 Dec; 55(5):583-9. PubMed ID: 5003621
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pipobroman in the treatment of some cases of polycythemia vera].
    Bignotti G; Visca U; Confalonieri C
    Haematologica; 1971; 56(3):157-62. PubMed ID: 5003588
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experiences with dibromodulcitol (NSC-104800) in solid tumors.
    Phillips RW; Brook J
    Cancer Chemother Rep; 1971 Dec; 55(5):567-73. PubMed ID: 4946081
    [No Abstract]   [Full Text] [Related]  

  • 5. New cytostatic drugs in the management of polycythaemia vera.
    Nagy G; Balázs C; Petrányi G
    Ther Hung; 1972; 20(1):10-3. PubMed ID: 5057661
    [No Abstract]   [Full Text] [Related]  

  • 6. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
    Penttilä O; Ikkala E
    Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Vaquez's polycythemia with 1-4, bis-3-bromopropionyl-piperazine. Study of 36 cases].
    Bilski-Pasquier G; Blanc CM; Bousser J
    Presse Med (1893); 1968 Oct; 76(41):1953-6. PubMed ID: 5248051
    [No Abstract]   [Full Text] [Related]  

  • 8. New cytostatic drugs in the management of polycythaemia vera.
    Nagy G; Balázs C; Petrányi G
    Acta Med Acad Sci Hung; 1971; 28(3):211-6. PubMed ID: 5153639
    [No Abstract]   [Full Text] [Related]  

  • 9. [Polycythemia vera].
    Nagy G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(4):381-97. PubMed ID: 4195487
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of dianhydrogalactitol in malignant glioma.
    Espana P; Wiernik PH; Walker MD
    Cancer Treat Rep; 1978 Aug; 62(8):1199-200. PubMed ID: 210944
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of polycythemia vera].
    Ernst P; Boye Nielsen J; Killman SE
    Nord Med; 1971 Dec; 86(50):1533. PubMed ID: 5135060
    [No Abstract]   [Full Text] [Related]  

  • 12. The management of polycythaemia vera with dibromomannitol.
    Tura S; Baccarani M
    Haematologia (Budap); 1970; 4(1):67-74. PubMed ID: 5522358
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I study of dibromodulcitol (NSC-104800).
    Andrews NC; Weiss AJ; Ansfield FJ; Rochlin DB; Mason JH
    Cancer Chemother Rep; 1971 Feb; 55(1):61-5. PubMed ID: 5121653
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of the treatment of polycythemia vera with Vercyte].
    Polubiec A; Kolakowska-Polubiec K
    Wiad Lek; 1969 Dec; 22(23):2139-44. PubMed ID: 4904660
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of long-term treatment of polycythemia vera with busulfan (Myleran) or dibromomannitol (Myelobromol): analysis of 4 clinical cases observed and treated during more than 7 years].
    Alberto P; Maurice PA
    Praxis; 1969 Sep; 58(38):1211-6. PubMed ID: 4982355
    [No Abstract]   [Full Text] [Related]  

  • 16. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
    Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
    Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of clinical usefulness of thiamphenicol in the management of patients with polycythemia vera].
    Yamauchi H; Kurabayashi H; Katahira H; Sawamura M; Karasawa M; Yatabe H; Sugita Y; Nogiwa E; Iwata N; Omine M
    Rinsho Ketsueki; 1986 Oct; 27(10):1843-9. PubMed ID: 3820609
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial of pipobroman (N,N'-bis-(3-bromopropionyl) piperazine) in eight patients with polycythemia vera].
    Miyazaki T; Ishizaki T; Maekawa I; Sano H; Idaka K
    Rinsho Ketsueki; 1972 Oct; 13(5):777-86. PubMed ID: 4674853
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of polycythemia vera with myleran].
    Krykowski E; Wislawska B; Polkowska-Kulesza E
    Przegl Lek; 1965; 21(7):481-3. PubMed ID: 5848465
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of triethyleneiminobenzoquinone on polycythemia vera].
    Molina de Bernadou ME; Segovia de Sasot AM; Rapaport de Sirvarjer S
    Sangre (Barc); 1967; 12(4):353-62. PubMed ID: 5614842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.